UK Markets closed

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.6300-0.2600 (-5.32%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 318.9480
52-week low 34.4400
50-day moving average 36.6164
200-day moving average 39.1935

Share statistics

Avg vol (3-month) 3257.61k
Avg vol (10-day) 3152.9k
Shares outstanding 540.62M
Implied shares outstanding 6N/A
Float 82.94M
% held by insiders 10.00%
% held by institutions 146.62%
Shares short (27 May 2021) 4278.78k
Short ratio (27 May 2021) 414.45
Short % of float (27 May 2021) 4N/A
Short % of shares outstanding (27 May 2021) 40.69%
Shares short (prior month 29 Apr 2021) 4263.18k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.13%
Return on equity (ttm)-29.78%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -40.41M
Net income avi to common (ttm)-41.75M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)159.26M
Total cash per share (mrq)36.43
Total debt (mrq)15.94M
Total debt/equity (mrq)8.90
Current ratio (mrq)11.51
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-35.91M
Levered free cash flow (ttm)N/A